Received Aug 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
A patient received only the liquid portion of Menveo; A patient received only the liquid portion of Menveo; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: A patient received only the liquid portion of Menveo) and inappropriate dose of vaccine administered (Verbatim: A patient received only the liquid portion of Menveo). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 05-AUG-2025 A pharmacy manager called to report that a patient received only the liquid portion of Menveo, which led to an inappropriate preparation of medication and inappropriate dose of vaccine administered. The health care professional asked what they should do next.